NCT03683784

Brief Summary

study the prevalence of type II diabetes mellitus, prevalence of newly diagnosed type II diabetic patients

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2017

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2017

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

September 24, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 25, 2018

Completed
Last Updated

September 25, 2018

Status Verified

September 1, 2018

Enrollment Period

10 months

First QC Date

September 24, 2018

Last Update Submit

September 24, 2018

Conditions

Diabetes Mellitus

Outcome Measures

Primary Outcomes (1)

  • Prevalence of diabetes in Fayoum

    Prevalence of diabetes in Fayoum governorate

    11 months

Study Arms (2)

Males

Male diabetics or male subjects proved to be diabetics

Female

Female diabetics or male subjects proved to be diabetics

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

obese persons,dyslipidemics ,apparently healthy individuals

You may qualify if:

  • community sample as obese persons,family history of diabetes,diabetics,hypertensives,dyslipidemics

You may not qualify if:

  • subjects known to have:chronic liver disease,CKD,Cushing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Ahmed A Hammad, MD

    Fayoum University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of internal medicine

Study Record Dates

First Submitted

September 24, 2018

First Posted

September 25, 2018

Study Start

January 1, 2017

Primary Completion

November 1, 2017

Study Completion

November 1, 2017

Last Updated

September 25, 2018

Record last verified: 2018-09